FDA Approves Zimmer’s Rosa Robot for Hip

Zimmer Biomet announced this morning that the FDA has given an additional approval for its Rosa robotic surgical system. The Rosa Hip system has gained FDA approval for robotically-assisted direct anterior total hip replacement. The system is designed to help surgeons prep for positioning and component impaction while and then peri-operatively with quantifying cup orientation, leg length, offset and other critical steps of an anterior approach total hip replacement.

This approval adds to the company’s suite of robotics technologies including Rosa Knee (for total knee replacement), Rosa Partial Knee, and Rosa One for neuro and spine. This approval further augments Zimmer’s offering in digital and robotic technologies called ZBEdge.

This approval was in-line with expectations despite some lags at the FDA related to COVID. The question remains as to when when Rosa Hip will be fully launching in the market.

Company analysts expect a limited launch to commence in this latter half of 2021 and we’ll likely see it presented with fanfare at the AAOS meeting in San Diego later this month.

Surgical robotics is a major strategic trend in orthopedics.